Aadi Bioscience (AADI)
(Real Time Quote from BATS)
$1.89 USD
+0.05 (2.72%)
Updated May 9, 2024 12:23 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AADI 1.89 +0.05(2.72%)
Will AADI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AADI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AADI
Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?
Is Aadi Bioscience (AADI) Stock Outpacing Its Medical Peers This Year?
AADI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Aadi Bioscience (AADI) Outperforming Other Medical Stocks This Year?
Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Misses Revenue Estimates
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates
Other News for AADI
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Aadi Bioscience Inc (AADI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Aadi Bioscience, Inc. (AADI) Q1 2024 Earnings Call Transcript
AADI Stock Earnings: Aadi Bioscience Misses EPS, Misses Revenue for Q1 2024
Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update